[Federal Register Volume 78, Number 5 (Tuesday, January 8, 2013)]
[Notices]
[Pages 1216-1217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-00089]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: January 24, 2013.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
discuss Biosafety measures for research with highly pathogenic avian 
influenza H5N1 strains that have the potential to be transmissible 
through respiratory droplets and related data management activities. 
Please check the meeting agenda at OBA Meetings Page (available at 
the following URL: http://oba.od.nih.gov/rdna_rac/rac_meetings.html) for more information.
    Place: National Institutes of Health, Building 45, Lower Level, 
Conference Room C1-C2, 45 Center Drive, Rockville, MD 20892.
    Contact Person: Chezelle George, Office of Biotechnology 
Activities, Office of Science Policy/OD, National Institutes of 
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-
9838, [email protected].

    Information is also available on the Institute's/Center's home 
page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any 
additional information for the meeting will be posted when 
available.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11,

[[Page 1217]]

1980) requires a statement concerning the official government 
programs contained in the Catalog of Federal Domestic Assistance. 
Normally NIH lists in its announcements the number and title of 
affected individual programs for the guidance of the public. Because 
the guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.
    OBA will offer those members of the public viewing the meeting via 
webcast (see link on OBA Meetings Page) the opportunity to submit 
comments to be read during the scheduled public comment periods. 
Individuals wishing to submit comments should use the comment form, 
which will accommodate comments up to 1500 characters, and will be 
available on the OBA Meetings Page during the meeting. Please submit 
your comment prior to the start of the public comment period. Please 
limit your comment to a statement that can be read in one to two 
minutes. Please include your name and affiliation with your comment.
    OBA will read comments into the record during the public comment 
periods that are specified on the agenda. Please note, while every 
effort is made to keep the meeting discussions to the times stated on 
the agenda, it is not unusual for the meeting to run ahead or behind 
schedule due to changes in the time needed to review a protocol. It is 
advisable to monitor the webcast to determine when public comments will 
be read. Comments submitted electronically will follow any comments by 
individuals attending the meeting in person. Comments will be read in 
the order received and your name and affiliation will be read with the 
comment. Please note OBA may not be able to read every comment received 
in the time allotted for public comment. Comments not read will become 
part of the public record.
    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.

    Dated: January 3, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-00089 Filed 1-7-13; 8:45 am]
BILLING CODE 4140-01-P